1. Home
  2. MRAM vs ASRT Comparison

MRAM vs ASRT Comparison

Compare MRAM & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRAM
  • ASRT
  • Stock Information
  • Founded
  • MRAM 2008
  • ASRT 1995
  • Country
  • MRAM United States
  • ASRT United States
  • Employees
  • MRAM N/A
  • ASRT N/A
  • Industry
  • MRAM Semiconductors
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MRAM Technology
  • ASRT Health Care
  • Exchange
  • MRAM Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • MRAM 121.1M
  • ASRT 123.9M
  • IPO Year
  • MRAM 2016
  • ASRT 1997
  • Fundamental
  • Price
  • MRAM $5.81
  • ASRT $1.14
  • Analyst Decision
  • MRAM Strong Buy
  • ASRT Strong Buy
  • Analyst Count
  • MRAM 2
  • ASRT 5
  • Target Price
  • MRAM $9.00
  • ASRT $3.35
  • AVG Volume (30 Days)
  • MRAM 101.2K
  • ASRT 437.0K
  • Earning Date
  • MRAM 10-30-2024
  • ASRT 11-06-2024
  • Dividend Yield
  • MRAM N/A
  • ASRT N/A
  • EPS Growth
  • MRAM N/A
  • ASRT N/A
  • EPS
  • MRAM 0.07
  • ASRT N/A
  • Revenue
  • MRAM $58,238,000.00
  • ASRT $132,186,000.00
  • Revenue This Year
  • MRAM N/A
  • ASRT N/A
  • Revenue Next Year
  • MRAM $8.94
  • ASRT $4.68
  • P/E Ratio
  • MRAM $79.46
  • ASRT N/A
  • Revenue Growth
  • MRAM N/A
  • ASRT N/A
  • 52 Week Low
  • MRAM $4.89
  • ASRT $0.73
  • 52 Week High
  • MRAM $10.50
  • ASRT $2.60
  • Technical
  • Relative Strength Index (RSI)
  • MRAM 53.49
  • ASRT 43.00
  • Support Level
  • MRAM $5.54
  • ASRT $1.15
  • Resistance Level
  • MRAM $6.08
  • ASRT $1.25
  • Average True Range (ATR)
  • MRAM 0.24
  • ASRT 0.07
  • MACD
  • MRAM 0.02
  • ASRT -0.01
  • Stochastic Oscillator
  • MRAM 68.40
  • ASRT 17.24

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA); and Asia-Pacific (APAC).

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: